StoneX Group
ATYR icon

StoneX Group’s aTyr Pharma ATYR Stock Holding History

StoneX Group’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$31.8K Buy
+2,625
New +$51K ﹤0.01% 1677
2024
Q4 		– Sell
-393
Closed -$27.6K – 946
2024
Q3 		$27.6K Buy
+393
New +$28.6K ﹤0.01% 615

Other funds holding ATYR

Kingswood Wealth Advisors
Kingswood Wealth Advisors San Diego, California $2.6B AUM 27.46% 1-Year Est. Return
Alpha Wealth Funds
Alpha Wealth Funds Park City, Utah $29.7M AUM 4.48% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Certuity
Certuity North Palm Beach, Florida $2.13B AUM 70.4% 1-Year Est. Return
Ares Financial Consulting
Ares Financial Consulting Calabasas, California $145M AUM 16.02% 1-Year Est. Return
Newbridge Financial Services Group
Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
EverSource Wealth Advisors
EverSource Wealth Advisors Birmingham, Alabama $3.11B AUM 21.48% 1-Year Est. Return
Root Financial Partners
Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

StoneX Group's ATYR Position: Q3 2026 in Review

StoneX Group opened a new position in aTyr Pharma (ATYR) in Q3 2026: 2,625 shares worth $31.8K. The stake represents ﹤0.01% of the portfolio and ranks #1677 among its holdings. This is a return to the name: StoneX Group previously reported a position in ATYR as recently as Q3 2024.

StoneX Group first reported a position in ATYR in Q3 2024 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold ATYR as of Q3 2026.

  • StoneX Group held 2,625 shares of aTyr Pharma worth $31.8K as of Q3 2026.
  • aTyr Pharma was a new StoneX Group position in Q3 2026.
  • aTyr Pharma made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1677 holding.
  • StoneX Group first reported a position in aTyr Pharma in Q3 2024 and has held it in 2 quarters since.
  • 17 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.